Stay updated on Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Sign up to get notified when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.
Latest website image capture
Clouds background image

Latest updates to the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recruitment status was updated to 'no longer looking for participants,' clarifying that enrollment is closed. The page also adds a How to Join a Study section and minor navigational/header updates (How to Read a Study Record, Common Questions), with a formatting/metadata change to the Interventions heading and a revision note.
    Difference
    0.5%
    Check dated 2026-06-13T01:07:52.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The revision history for the study record was updated from v3.5.4 to v3.5.5, representing a small update to the page documentation. This change does not alter study details, eligibility criteria, or reported results.
    Difference
    0.1%
    Check dated 2026-06-05T23:49:34.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the study record page. This represents a minor metadata/version update rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-05-15T15:12:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    This update advances the site’s displayed revision version in the page footer (v3.5.2 → v3.5.3) without altering the study record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:07:54.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Content appears unchanged aside from formatting and layout adjustments. No new or removed study data, eligibility criteria, or outcomes are observed.
    Difference
    0.1%
    Check dated 2026-03-26T04:22:40.000Z thumbnail image

Stay in the know with updates to Dolatav Clinical Trial: Nucleoside Sparing in HIV-1

Enter your email address, and we'll notify you when there's something new on the Dolatav Clinical Trial: Nucleoside Sparing in HIV-1 page.